# Tolerability to HS-20004 With Titration Administration in Type 2 Diabetic Patients

> **NCT02750007** · PHASE1 · UNKNOWN · sponsor: **Jiangsu Hansoh Pharmaceutical Co., Ltd.** · enrollment: 12 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** HS-20004

## Key facts

- **NCT ID:** NCT02750007
- **Lead sponsor:** Jiangsu Hansoh Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-12
- **Primary completion:** 2017-01
- **Final completion:** —
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2016-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02750007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02750007, "Tolerability to HS-20004 With Titration Administration in Type 2 Diabetic Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02750007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*